Frontal fibrosing alopecia: A review of disease pathogenesis.
Frontal fibrosing alopecia: A review of disease pathogenesis.
复制标题
DOI:
10.3389/fmed.2022.911944
复制
发表时间:
2022
影响因子:
3.9
通讯作者:
中科院分区:
文献类型:
--
作者:
Frontal fibrosing alopecia (FFA) is a primary patterned cicatricial alopecia that mostly affects postmenopausal women and causes frontotemporal hairline regression and eyebrow loss. Although the incidence of FFA has increased worldwide over the last decade, its etiology and pathology are still unclear. We cover the latest findings on its pathophysiology, including immunomodulation, neurogenic inflammation, and genetic regulation, to provide more alternatives for current clinical treatment. A persistent inflammatory response and immune privilege (IP) collapse develop and lead to epithelial hair follicle stem cells (eHFSCs) destruction and epithelial-mesenchymal transition (EMT) in the bulge area, which is the key process in FFA pathogenesis. Eventually, fibrous tissue replaces normal epithelial tissue and fills the entire hair follicle (HF). In addition, some familial reports and genome-wide association studies suggest a genetic susceptibility or epigenetic mechanism for the onset of FFA. The incidence of FFA increases sharply in postmenopausal women, and many FFA patients also suffer from female pattern hair loss in clinical observation, which suggests a potential association between FFA and steroid hormones. Sun exposure and topical allergens may also be triggers of FFA, but this conjecture has not been proven. More evidence and cohort studies are needed to help us understand the pathogenesis of this disease. Different hypothetical triggers, such as facial soap, cosmetics, sunscreen, or stressful conditions, can cause FFA in potentially genetically susceptible individuals. PPAR-γ/TGF-β pathway plays an essential role in EMT and fibrosis. mTOR signaling works as a modulator of PPAR-γ activity and lipid homeostasis. Arrows and lines indicate a regular relationship between two elements mTOR: mammalian target of rapamycin; PPAR-γ: peroxisome proliferator-activated receptor γ; DHEA: dehydroepiandrosterone; HF: hair follicle; IFN: interferon; TGF-β: transforming growth factor-β; IP: immune privilege; EMT: epithelial-mesenchymal transition; SP: substance P; NK-1: Neurokinin-1. Created with BioRender.com (accessed on 7 February 2022).
登录
查看更多内容
影响因子:
27.4
作者:
Gonzalez, Estrella Garcia;Selvi, Enrico;Distler, Joerg H. W.
通讯作者:
Distler, Joerg H. W.
影响因子:
7.3
作者:
Harries, Matthew J.;Meyer, Katja;Paus, Ralf
通讯作者:
Paus, Ralf
影响因子:
6.5
作者:
Imanishi, Hisayoshi;Ansell, David M.;Paus, Ralf
通讯作者:
Paus, Ralf
影响因子:
6.5
作者:
Karnik, Pratima;Tekeste, Zenar;Mirmirani, Paradi
通讯作者:
Mirmirani, Paradi
影响因子:
3.6
作者:
Doche, Isabella;Wilcox, George L.;Hordinsky, Maria K.
通讯作者:
Hordinsky, Maria K.